Park Ha Biological Technology Co., Ltd. BYAH
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-41.38
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.5M | $2.4M | $2.5M | $1.9M | — |
| Cost of revenue | $142.5K | $195.3K | $311.0K | $509.2K | — |
| Gross profit | $2.4M | $2.2M | $2.1M | $1.4M | — |
| R&D | $238.2K | $36.7K | $30.9K | $60.7K | — |
| SG&A | $25.5M | $814.9K | $485.0K | $707.5K | — |
| Total operating expenses | $26.5M | $1.4M | $967.6K | $1.2M | — |
| Operating income | -$24.1M | $793.7K | $1.2M | $197.0K | — |
| Interest expense | $41 | — | — | $194 | — |
| Pre-tax income | -$24.1M | $793.4K | $1.2M | $190.0K | — |
| Income tax | $280.6K | $314.9K | $329.5K | $1.3K | — |
| Net income | -$24.4M | $478.6K | $852.0K | $191.3K | — |
| EPS, basic | -41.38 | 0.96 | 1.70 | 0.01 | — |
| EPS, diluted | -41.38 | 0.96 | 1.70 | 0.01 | — |
| Shares, diluted (wtd. avg.) | 588,866 | 500,000 | 500,000 | 25.0M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | $3.8M | $547.5K | $1.0M | $574.7K | $72.7K |
| Receivables | $255.8K | $330.9K | $361.7K | — | — |
| Inventory | $75.2K | $71.5K | $95.9K | — | — |
| Total current assets | $5.5M | $2.8M | $2.2M | — | — |
| Property, plant and equipment | $158.0K | $104.0K | $38.6K | — | — |
| Other intangibles | $6.6K | $7.6K | $8.4K | — | — |
| Total assets | $6.0M | $3.1M | $2.3M | — | — |
| Accounts payable | $12.0K | $24.1K | $197.2K | — | — |
| Total current liabilities | $1.9M | $1.5M | $1.2M | — | — |
| Total liabilities | $2.0M | $1.6M | $1.3M | — | — |
| Retained earnings | -$24.2M | $271.8K | -$105.2K | — | — |
| Total equity | $4.0M | $1.5M | $1.0M | $150.3K | -$578.2K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating cash flow | $85.9K | $960.5K | $126.5K | $1.4M | — |
| Depreciation and amortisation | $108.4K | $21.7K | $19.1K | — | — |
| Stock-based compensation | $24.1M | — | — | — | — |
| Capital expenditure | $88.8K | $85.6K | $22.7K | $11.9K | — |
| Investing cash flow | -$572.9K | -$508.1K | $1.0M | -$1.5M | — |
| Financing cash flow | $3.7M | -$957.4K | -$676.9K | $669.7K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-057152.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $1.9M | $2.5M | $2.4M | $2.5M |
| Gross profit | — | $1.4M | $2.1M | $2.2M | $2.4M |
| Net income | — | $191.3K | $852.0K | $478.6K | -$24.4M |
Others in SIC 2840
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| PG | PROCTER & GAMBLE Co | $374.28B | 24.3x | 3.3% |
| ECL | ECOLAB INC. | $80.88B | 39.6x | 2.2% |
| CHD | CHURCH & DWIGHT CO INC /DE/ | $24.95B | 34.8x | 1.6% |
| SCL | STEPAN CO | $1.45B | 31.2x | 7.0% |
| UL | UNILEVER PLC | — | — | — |
| WNW | Meiwu Technology Co Ltd | — | — | 4,368.0% |